by Kenjiro Lolling | Jan 21, 2025 | News
Toxys and Unilever have joined forces to advance New Approach Methodologies (NAMs) for assessing cellular stress—an essential factor in Next Generation Risk Assessment (NGRA). This collaboration aims to refine non-animal testing approaches by validating ToxProfiler,...
by Kenjiro Lolling | Jan 9, 2025 | Uncategorized
Congratulations to the team at Alesta Therapeutics on raising an impressive €65 million in their Series A financing! Led by Frazier Life Sciences and Droia Ventures, this round will push their work in rare disease therapies to new levels. Their lead program, ALE1,...
by Kenjiro Lolling | Dec 20, 2024 | News
How does collaboration work at different scales: provincial (e.g., EBZ and the province), regional (e.g., Holland Rijnland), and cluster-specific (e.g., Leiden Bio Science Park)? These interconnected levels play a vital role in building a stronger South Holland. In...
by Kenjiro Lolling | Dec 19, 2024 | News
Leiden Bio Science Park (LBSP) had the honor of hosting a Swiss delegation, organized by Roche, Novartis, Rijksdienst voor Ondernemend Nederland, Health Holland, and other partners. The visit showcased the innovative collaborations and research driving advancements in...
by Kenjiro Lolling | Dec 13, 2024 | News
The labor market in the Netherlands is under significant strain, and healthcare is one of the sectors most affected. This impacts all of us. Ahead of an upcoming Commission debate on Labor Market Policy in Healthcare in our national parliament (Tweede Kamer) on...